Antiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities (2013)
Source: Clinical Colorectal Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS, METÁSTASE NEOPLÁSICA, HIPERTENSÃO, QUIMIOTERÁPICOS (EFEITOS), TROMBOEMBOLISMO, ANTICORPOS MONOCLONAIS
ABNT
FERRAROTTO, Renata e HOFF, Paulo Marcelo Gehm. Antiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities. Clinical Colorectal Cancer, v. 12, n. 1, p. 1-7, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.clcc.2012.06.002. Acesso em: 06 jun. 2024.APA
Ferrarotto, R., & Hoff, P. M. G. (2013). Antiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities. Clinical Colorectal Cancer, 12( 1), 1-7. doi:10.1016/j.clcc.2012.06.002NLM
Ferrarotto R, Hoff PMG. Antiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities [Internet]. Clinical Colorectal Cancer. 2013 ; 12( 1): 1-7.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.clcc.2012.06.002Vancouver
Ferrarotto R, Hoff PMG. Antiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities [Internet]. Clinical Colorectal Cancer. 2013 ; 12( 1): 1-7.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.clcc.2012.06.002